A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)

Table 5 Results of the QHES assessment

Study	1	2	3	4	5	6	7	8	9	10	11	12	13	14	15	16	Score
Wang et al. (2013) [16]	√	√	x	√	√	√	√	√	√	x	x	√	√	x	x	√	65
Vergnenegre et al. (2012) [13]	√	√	x	√	x	√	x	√	x	x	√	√	x	x	√	√	51
Walleser et al. (2012) [14]	√	√	x	√	√	√	√	√	x	√	x	√	x	x	√	x	61
Klein et al. (2010) [15]	√	√	x	x	x	x	x	√	x	√	√	√	√	x	√	√	57
Araújo et al. (2008) [17]	√	√	x	√	√	√	√	√	x	√	√	x	√	x	x	√	62
Carlson et al. (2008) [12]	√	√	x	√	√	√	√	√	√	√	√	√	√	√	√	√	92
Lewis et al. (2010) [18]	√	√	x	√	x	√	√	√	x	√	√	x	√	x	√	√	61
Thongprasert et al. (2012) [19]	√	√	x	√	x	√	x	√	x	√	√	√	√	x	√	x	61
Cromwell et al. (2011) [20]*	√	√	√	√	x	√	√	√	√	√	√	n.a.	n.a.	√	√	√	76
Cromwell et al. (2012) [21]*	√	√	√	√	x	√	√	√	√	√	√	n.a.	n.a.	√	√	√	76
Bradbury et al. (2010) [22]*	√	√	√	√	√	√	√	√	√	x	√	n.a.	n.a.	√	√	√	79
Zhu et al. (2013) [23]	√	√	x	√	√	√	x	√	√	√	√	√	x	√	√	√	80
Chouaid et al. (2012) [24]	√	√	x	√	x	√	x	x	x	x	√	x	√	x	√	√	43
Chouaid et al. (2013) [25]	√	√	x	√	x	√	x	x	√	x	√	x	x	x	√	√	44
Carlson et al. (2009) [26]	√	√	x	√	√	√	√	√	x	x	√	√	√	√	√	√	78
Giuliani et al. (2010) [27]	√	√	x	√	x	√	x	√	x	√	√	√	√	x	√	√	64
Ahn et al. (2011) [28]	√	√	x	√	√	√	√	√	x	√	√	√	√	x	√	√	78
Goulart et al. (2011) [29]	√	√	x	√	√	√	√	√	√	x	√	√	√	√	√	√	86
Klein et al. (2009) [30]	√	√	x	√	x	x	x	x	x	√	√	√	√	√	√	√	57
Statement frequency	19	19	3	18	9	17	11	16	8	12	17	12	12	8	17	17

ISSN: 1471-2466